-+ 0.00%
-+ 0.00%
-+ 0.00%

Canaccord Genuity Maintains Buy on Artivion, Lowers Price Target to $48

Benzinga·02/13/2026 19:23:33
Listen to the news
Canaccord Genuity analyst William Plovanic maintains Artivion (NYSE:AORT) with a Buy and lowers the price target from $51 to $48.